ENZON PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Enzon Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q2 2024.
  • Enzon Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 74.2M shares, unchanged year-over-year.
  • Enzon Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 74.2M shares, unchanged from 2022.
  • Enzon Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 74.2M shares.
  • Enzon Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 74.2K shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 74.2M 0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 74.2M 0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 74.2M 0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 74.2M 0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 74.2M +74.1M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 74.2M +74.1M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 74.2M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 74.2M 0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 74.2K* 0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 74.2K* 0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q3 2021 74.2M +30M +67.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 74.2K* -44.1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 74.2K* -44.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-26
Q4 2020 51.1M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-25
Q3 2020 44.2M 0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 44.2M 0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 44.2M 0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q3 2019 44.2M 0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 44.2M 0 0% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 44.2M 0 0% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q3 2018 44.2M 0 0% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 44.2M 0 0% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 44.2M 0 0% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 44.2M 0 0% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-21
Q3 2017 44.2M +1K +0% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 44.2M +95K +0.22% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 44.2M 0 0% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 44.2M +18K +0.04% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-21
Q3 2016 44.2M +32K +0.07% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 44.1M -62K -0.14% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 44.2M +34K +0.08% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 44.2M +72K +0.16% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-24
Q3 2015 44.2M +51K +0.12% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 44.2M +70K +0.16% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 44.2M +89K +0.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 44.1M +343K +0.78% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-21
Q3 2014 44.1M +210K +0.48% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 44.1M +383K +0.88% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 44.1M +399K +0.91% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 43.8M -2.95M -6.32% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-05
Q3 2013 43.9M -2.47M -5.32% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 43.7M -4.45M -9.23% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 43.7M -4.6M -9.53% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 46.7M -5.18M -9.97% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 46.4M -2.34M -4.81% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 48.2M -4.88M -9.19% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 48.3M -9.71M -16.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 51.9M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-14
Q3 2011 48.7M -12.1M -19.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 53.1M -7.8M -12.8% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-21
Q1 2011 58M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-02
Q3 2010 60.8M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 60.8M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.